These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2558699)

  • 21. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and disposition of pipecuronium bromide in dogs with and without ligated renal pedicles.
    Khuenl-Brady KS; Sharma M; Chung K; Miller RD; Agoston S; Caldwell JE
    Anesthesiology; 1989 Dec; 71(6):919-22. PubMed ID: 2556065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the haemodynamic effects of pipecuronium and pancuronium during fentanyl anaesthesia.
    Stanley JC; Carson IW; Gibson FM; McMurray TJ; Elliott P; Lyons SM; Mirakhur RK
    Acta Anaesthesiol Scand; 1991 Apr; 35(3):262-6. PubMed ID: 1645492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of renal failure on the pharmacokinetics and duration of action of pipecuronium bromide in patients anesthetized with halothane and nitrous oxide.
    Caldwell JE; Canfell PC; Castagnoli KP; Lynam DP; Fahey MR; Fisher DM; Miller RD
    Anesthesiology; 1989 Jan; 70(1):7-12. PubMed ID: 2536254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative clinical study of pipecurium bromide and pancuronium bromide.
    Boros M; Szenohradszky J; Marosi G; Tóth I
    Arzneimittelforschung; 1980; 30(2a):389-93. PubMed ID: 6248087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism of non-depolarising neuromuscular blockade by aminopyridines in cats.
    Riesz M; Kápáti E; Szporny L
    J Pharm Pharmacol; 1986 Feb; 38(2):156-8. PubMed ID: 2870165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A pharmacodynamic study of pipecuronium bromide (Arduan) in newborn infants, infants and children].
    Praefort L
    Cah Anesthesiol; 1990 Mar; 38(2):79-85. PubMed ID: 2163731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observations on the neuromuscular blocking action of pipecuronium in the dog.
    Jones RS
    Res Vet Sci; 1987 Jul; 43(1):101-3. PubMed ID: 2820005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.
    Naguib M; Abdulatif M
    Can J Anaesth; 1991 Sep; 38(6):722-7. PubMed ID: 1655299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacologic effects of pipecuronium bromide (Arduan)].
    Kárpáti E; Bíró K
    Acta Pharm Hung; 1992 May; 62(3):121-6. PubMed ID: 1323913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of pipecuronium and pancuronium in patients undergoing coronary artery bypass grafting.
    Tassonyi E; Neidhart P; Pittet JF; Morel DR; Gemperle M
    Anesthesiology; 1988 Nov; 69(5):793-6. PubMed ID: 2847596
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pipecurium bromide (Arduan) compared with pancuronium bromide (Pavulon) and their effects on newborn infants delivered by cesarean section].
    Marinova M; Smilov I; Savova I; Mitev L; Mincheva-Saeva M
    Akush Ginekol (Sofiia); 1987; 26(4):48-51. PubMed ID: 2823623
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical pharmacology of pipecuronium in infants and children during halothane anesthesia.
    Sarner JB; Brandom BW; Dong ML; Pickle D; Cook DR; Weinberger MJ
    Anesth Analg; 1990 Oct; 71(4):362-6. PubMed ID: 2169211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide.
    Kárpáti E; Biró K
    Arzneimittelforschung; 1980; 30(2a):346-57. PubMed ID: 6155921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl.
    Wierda JM; Richardson FJ; Agoston S
    Anesth Analg; 1989 Mar; 68(3):208-13. PubMed ID: 2537588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopharmacology of Arduan].
    Mészáros C
    Acta Pharm Hung; 1992 May; 62(3):133-8. PubMed ID: 1354406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetics and metabolism of pipecuronium bromide (Arduan)].
    Vereczkey L
    Acta Pharm Hung; 1992 May; 62(3):127-31. PubMed ID: 1323914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical, electromyographic and electromechanographic studies of the nondepolarizing muscle relaxant pipecurium bromide (Arduan)].
    Stoianov E; Shtŭrbova M; Marinova M
    Khirurgiia (Sofiia); 1988; 41(5):35-7. PubMed ID: 2851068
    [No Abstract]   [Full Text] [Related]  

  • 39. [Kinetic study of the hydrolysis of pipecuronium bromide. I Separation and quantitative determination of pipecuronium bromide and its hydrolysis-derivatives by thin-layer chromatography and densitometry].
    Kovács P; Takácsi Nagy G
    Acta Pharm Hung; 1983 Mar; 53(2):56-63. PubMed ID: 6310952
    [No Abstract]   [Full Text] [Related]  

  • 40. Myasthenia gravis and pipecuronium--report of two cases.
    Naguib M; Sari-Kouzel A; Ashour M; Seraj M; Messahel F
    Middle East J Anaesthesiol; 1992 Feb; 11(4):381-90. PubMed ID: 1320731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.